1月30日，中国黄金盘中下跌3.48%，截至09:35，报13.03元/股，成交16.63亿元，换手率7.66%，总市值 218.90亿元。 资金流向方面，主力资金净流入1.26亿元，特大单买入4.73亿元，占比28.42%，卖出3.73亿元，占比 22.46%；大单买入3.58亿元，占比21.52%，卖出3.31亿元，占比19.92%。 中国黄金今年以来股价涨59.88%，近5个交易日涨41.32%，近20日涨59.88%，近60日涨58.13%。 分红方面，中国黄金A股上市后累计派现25.20亿元。近三年，累计派现18.48亿元。 机构持仓方面，截止2025年9月30日，中国黄金十大流通股东中，香港中央结算有限公司位居第五大流 通股东，持股1758.66万股，相比上期减少612.63万股。黄金股ETF（517520）位居第九大流通股东，持 股966.81万股，为新进股东。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑： ...

截至9月30日，思特威股东户数1.83万，较上期增加38.46%；人均流通股17619股，较上期减少27.78%。 2025年1月-9月，思特威实现营业收入63.17亿元，同比增长50.14%；归母净利润6.99亿元，同比增长 155.99%。 分红方面，思特威A股上市后累计派现1.76亿元。 1月22日，思特威盘中下跌2.03%，截至10:15，报101.01元/股，成交6.51亿元，换手率1.95%，总市值 406.37亿元。 资金流向方面，主力资金净流出2382.57万元，特大单买入7098.88万元，占比10.90%，卖出7284.63万 元，占比11.19%；大单买入2.23亿元，占比34.33%，卖出2.45亿元，占比37.70%。 思特威今年以来股价涨6.23%，近5个交易日涨6.67%，近20日涨11.10%，近60日跌9.91%。 资料显示，思特威(上海)电子科技股份有限公司位于上海市闵行区田林路889号科技绿洲四期8号楼，成 立日期2017年4月13日，上市日期2022年5月20日，公司主营业务涉及高性能CMOS图像传感器芯片的研 发、设计和销售。主营业务收入构成为：芯片销售100.00% ...

Core Viewpoint - Aotai Bio plans to repurchase shares through centralized bidding, with a total amount between 100 million and 200 million yuan, and a maximum repurchase price of 85.00 yuan per share, which is 23.69% higher than the current price of 68.72 yuan [1] Group 1: Company Overview - Aotai Bio, established on April 17, 2009, is located in Hangzhou, Zhejiang Province, and was listed on March 25, 2021 [1] - The company specializes in the research, production, and sales of in vitro diagnostic reagents, with revenue composition as follows: infectious diseases 42.27%, drug and substance abuse 26.74%, others 9.72%, women's health 8.81%, COVID-19 testing 6.60%, tumors 3.77%, myocardium 1.60%, and others 0.49% [1] Group 2: Financial Performance - As of October 31, Aotai Bio had 5,665 shareholders, a decrease of 1.29% from the previous period, with an average of 13,994 circulating shares per person, an increase of 1.31% [2] - For the period from January to September 2025, Aotai Bio achieved operating revenue of 633 million yuan, a year-on-year increase of 2.44%, while net profit attributable to the parent company was 190 million yuan, a decrease of 3.91% [2] Group 3: Shareholder Information - Aotai Bio has distributed a total of 1.28 billion yuan in dividends since its A-share listing, with 955.6 million yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the sixth largest shareholder with 2.1873 million shares, a decrease of 387,400 shares from the previous period, while Guotai Junan Value Advantage Flexible Allocation Mixed A (000362) entered as the ninth largest shareholder with 713,300 shares [3]

资料显示，福建龙净环保股份有限公司位于福建省龙岩市新罗区工业中路19号，成立日期1998年2月23 日，上市日期2000年12月29日，公司主营业务涉及除尘、脱硫、脱硝、物料输送、脱硫运营、电站工程 总包等。主营业务收入构成为：环保设备制造64.93%，新能源业务24.59%，项目运营收入7.34%，其他 (补充)2.27%，土壤修复0.87%。 龙净环保所属申万行业为：环保-环保设备Ⅱ-环保设备Ⅲ。所属概念板块包括：生态林业、PM2.5、新 材料、氢能源、增持回购等。 1月21日，龙净环保盘中下跌2.01%，截至13:26，报15.62元/股，成交1.22亿元，换手率0.61%，总市值 198.38亿元。 资金流向方面，主力资金净流出1695.27万元，特大单买入0.00元，占比0.00%，卖出897.95万元，占比 7.35%；大单买入1440.77万元，占比11.79%，卖出2238.09万元，占比18.31%。 龙净环保今年以来股价跌4.23%，近5个交易日涨0.39%，近20日跌2.74%，近60日跌1.14%。 截至9月30日，龙净环保股东户数4.44万，较上期增加0.04%；人均流通股28630 ...

Group 1 - The stock price of Yongtai Energy increased by 2.47% on January 20, reaching 1.66 CNY per share, with a trading volume of 1.074 billion CNY and a turnover rate of 3.02%, resulting in a total market capitalization of 36.217 billion CNY [1] - Since the beginning of the year, Yongtai Energy's stock price has risen by 5.73%, with a slight decline of 0.60% over the last five trading days, a 3.75% increase over the last 20 days, and a 0.61% increase over the last 60 days [2] - Yongtai Energy's main business segments include electricity (73.28% of revenue), coal (23.77%), and other businesses (2.95%) [2] Group 2 - As of September 30, 2025, Yongtai Energy reported a revenue of 17.728 billion CNY, a year-on-year decrease of 20.77%, and a net profit attributable to shareholders of 198 million CNY, down 86.48% year-on-year [2] - The company has distributed a total of 1.741 billion CNY in dividends since its A-share listing, with 122 million CNY distributed over the last three years [3] - The top ten circulating shareholders of Yongtai Energy include Southern CSI 500 ETF, holding 323 million shares, a decrease of 6.6534 million shares from the previous period, and Hong Kong Central Clearing Limited, holding 258 million shares, an increase of 6.3687 million shares [3]

Group 1 - The core viewpoint of the news is that China Gold's stock has shown a positive trend with a 2.08% increase on January 20, reaching 8.35 yuan per share, with a total market capitalization of 14.028 billion yuan [1] - As of September 30, China Gold's revenue for the first nine months of 2025 was 45.764 billion yuan, a year-on-year decrease of 1.74%, while the net profit attributable to shareholders was 335 million yuan, down 55.08% year-on-year [2] - The company primarily engages in the research, design, production, sales, and brand operation of gold jewelry products, with 98.83% of its revenue coming from gold products [1] Group 2 - China Gold's stockholder count increased by 2.57% to 121,000 as of September 30, while the average circulating shares per person decreased by 2.51% to 13,882 shares [2] - The company has distributed a total of 2.52 billion yuan in dividends since its A-share listing, with 1.848 billion yuan distributed in the last three years [3] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 17.5866 million shares, a decrease of 6.1263 million shares from the previous period [3]

Core Viewpoint - Stone Technology's stock has experienced a decline in recent trading sessions, with a current market capitalization of 39.708 billion yuan and a year-to-date price increase of only 0.78% [1] Group 1: Stock Performance - On January 20, Stone Technology's stock fell by 2.01%, trading at 153.25 yuan per share with a turnover of 493 million yuan and a turnover rate of 1.23% [1] - The stock has seen a decline of 3.33% over the past five trading days, 2.53% over the past 20 days, and 17.78% over the past 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Stone Technology reported a revenue of 12.066 billion yuan, representing a year-on-year growth of 72.22%, while the net profit attributable to shareholders decreased by 29.51% to 1.038 billion yuan [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Stone Technology was 15,900, a decrease of 8.77% from the previous period, with an average of 16,251 circulating shares per shareholder, an increase of 9.76% [2] - The company has distributed a total of 1.463 billion yuan in dividends since its A-share listing, with 1.052 billion yuan distributed over the past three years [3] Group 4: Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder, holding 14.5491 million shares, an increase of 4.4262 million shares from the previous period [3] - The top ten circulating shareholders include various ETFs, with notable changes in holdings among them, such as a decrease in shares held by E Fund's ETFs and an increase in shares held by Huatai-PineBridge's ETF [3]

Group 1 - The core viewpoint of the news is that Tai En Kang's stock has shown a positive trend with a 7.59% increase year-to-date and a market capitalization of 13.271 billion yuan as of January 20 [1] - As of January 20, Tai En Kang's stock price was 31.19 yuan per share, with a trading volume of 1.29 billion yuan and a turnover rate of 1.39% [1] - The company has a diverse revenue structure, with major contributions from gastrointestinal drugs (32.62%), ophthalmic drugs (25.05%), traditional Chinese medicine and external drugs (21.08%), and sexual health products (21.06%) [1] Group 2 - As of September 30, the number of Tai En Kang's shareholders increased by 9.32% to 12,000, while the average circulating shares per person decreased by 8.53% to 25,381 shares [2] - For the period from January to September 2025, Tai En Kang reported a revenue of 526 million yuan, a year-on-year decrease of 8.13%, and a net profit attributable to shareholders of 31.4052 million yuan, down 73.00% year-on-year [2] - Since its A-share listing, Tai En Kang has distributed a total of 460 million yuan in dividends, with 377 million yuan distributed over the past three years [3]

资料显示，山推工程机械股份有限公司位于山东省济宁市高新区327国道58号,香港铜锣湾勿地臣街1号 时代广场2座31楼，成立日期1993年12月14日，上市日期1997年1月22日，公司主营业务涉及建筑工程机 械、矿山机械、农田基本建设机械、收获机械及配件的研究、开发、制造、销售、租赁、维修及技术咨 询服务。主营业务收入构成为：工程机械主机产品73.25%，工程机械配件及其他19.45%，其他(补 充)7.31%。 1月20日，山推股份盘中上涨2.01%，截至10:51，报12.70元/股，成交1.74亿元，换手率1.05%，总市值 190.52亿元。 资金流向方面，主力资金净流出1182.46万元，特大单买入1514.81万元，占比8.70%，卖出1288.32万 元，占比7.40%；大单买入3428.34万元，占比19.69%，卖出4837.30万元，占比27.78%。 山推股份今年以来股价涨6.10%，近5个交易日涨4.01%，近20日涨11.21%，近60日涨8.09%。 分红方面，山推股份A股上市后累计派现13.45亿元。近三年，累计派现5.26亿元。 机构持仓方面，截止2025年9月30日，山推股份 ...

Core Viewpoint - Meihua Biological Technology Group Co., Ltd. has shown a positive stock performance with a 6.42% increase year-to-date and a significant rise in net profit, indicating potential growth in the amino acid market [1][2]. Company Overview - Meihua Biological, established on February 9, 1995, and listed on February 17, 1995, is located in Langfang, Hebei Province. The company specializes in the research, production, and sales of amino acid products [1]. - The main revenue sources are feed amino acids (46.09%), flavor enhancers (29.04%), by-products (15.38%), other products (7.47%), and pharmaceutical amino acids (2.01%) [1]. Financial Performance - For the period from January to September 2025, Meihua Biological reported a revenue of 18.215 billion yuan, a year-on-year decrease of 2.49%, while net profit attributable to shareholders increased by 51.61% to 3.025 billion yuan [2]. - The company has distributed a total of 12.047 billion yuan in dividends since its A-share listing, with 4.075 billion yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 13.10% to 66,700, while the average number of circulating shares per person decreased by 13.09% to 42,058 shares [2]. - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 18.336 million shares, and new entrants like Guotai CSI Livestock Breeding ETF and Southern S&P China A-share Large Cap Dividend Low Volatility 50 ETF [3].